Recent Updates
Recently added Catalysts
CTMX Positive Sentiment Score: 65/100

CytomX Therapeutics to Present at the Jefferies Healthcare Conference

Thursday, June 1, 2023 1 min read
Key Takeaway: CytomX Therapeutics announced that its CEO, Sean McCarthy, will present at the upcoming Jefferies Healthcare Conference on June 8. The event will include a live webcast of the presentation, accessible on the company's website. Additionally, CytomX management will hold one-on-one meetings with registered investors during the conference, indicating engagement with stakeholders.

Market Sentiment Analysis

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will present at the Jefferies Healthcare Conference on Thursday, June 8 at 4:00 p.m. ET.
A live webcast of the fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Investor and Media Contact:
Stern Investor Relations
stephanie.ascher@sternir.com

Frequently Asked Questions

When will CytomX Therapeutics present at the Jefferies Healthcare Conference?

CytomX Therapeutics will present on June 8, 2023, at 4:00 p.m. ET.

Where can I watch the CytomX presentation live?

The live webcast will be available on CytomX’s Events and Presentations page.

Who will represent CytomX Therapeutics at the conference?

Sean McCarthy, D.Phil., CEO and chairman, will represent CytomX.

Will there be one-on-one meetings with CytomX management?

Yes, management will meet with registered investors at the conferences.

What is the trademark associated with CytomX Therapeutics?

Probody is a registered trademark of CytomX Therapeutics, Inc.

Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics Jefferies Healthcare Conference Sean McCarthy localized biologics
Last updated: Jun 1, 2023